| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.94B | 43.42B | 41.28B | 39.20B | 35.92B | 37.20B |
| Gross Profit | 10.06B | 9.82B | 9.29B | 8.07B | 8.03B | 8.31B |
| EBITDA | 2.15B | 1.96B | 4.59B | 2.06B | 1.93B | 1.91B |
| Net Income | 31.00M | -120.00M | 2.70B | 931.00M | 958.00M | 727.00M |
Balance Sheet | ||||||
| Total Assets | 42.53B | 40.84B | 39.95B | 38.18B | 36.23B | 38.20B |
| Cash, Cash Equivalents and Short-Term Investments | 303.00M | 665.00M | 2.57B | 2.05B | 2.33B | 2.35B |
| Total Debt | 5.32B | 4.56B | 4.59B | 7.27B | 6.18B | 5.77B |
| Total Liabilities | 23.77B | 22.18B | 21.02B | 21.68B | 20.55B | 23.11B |
| Stockholders Equity | 18.75B | 18.65B | 18.93B | 16.50B | 15.68B | 15.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.51B | 1.62B | -1.26B | -40.00M | -112.00M |
| Operating Cash Flow | 0.00 | 1.23B | 3.06B | -694.00M | 1.74B | 1.08B |
| Investing Cash Flow | 0.00 | -2.62B | 515.00M | -317.00M | -1.65B | -1.22B |
| Financing Cash Flow | 0.00 | -513.00M | -3.06B | 730.00M | -113.00M | 418.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥11.90B | 11.75 | ― | 3.83% | 0.58% | -9.72% | |
74 Outperform | ¥13.77B | 9.05 | ― | 2.81% | 0.23% | -8.64% | |
74 Outperform | ¥10.78B | 3.90 | ― | 2.91% | 2.56% | 17.52% | |
65 Neutral | ¥8.35B | 43.69 | ― | 3.87% | 3.06% | -75.19% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥66.78B | 22.52 | ― | 1.49% | -8.92% | 1.67% | |
56 Neutral | ¥9.72B | 93.01 | ― | 4.72% | 7.32% | -93.45% |